Yatharth Hospital EGM clears Advent backed Rasmalai preferential issue

Board & Shareholder Meetings View source PDF Explain this filing

YATHARTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.8%Reaction day

₹984.90

prior close

₹991.70

announcement price

After-mkt

timing

Nifty Microcap 250market+0.7%+0.1% vs market

Hospital peers, median of 26sector-0.7%+1.5% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 1.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.7

15m

-0.6

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.8+0.7+0.1-0.7+1.5

Next day

-1.7-1.0-0.7-1.9+0.2

-6.5-3.6-2.9-3.5-3.0

-6.7-4.5-2.1-4.2-2.5

-6.3-6.8+0.4-5.3-1.1

-6.1-6.4+0.3-4.7-1.4

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Yatharth Hospital held its first EGM for 2026-27 on October 15, 2026 via video conferencing. Quorum was present with 74 members attending. Five resolutions were put to e-vote: increase in authorised share capital, preferential issue of equity shares and warrants to Rasmalai Limited (Advent International affiliate), special rights for the investor, amended articles for promoter rights, and an upside share arrangement. Management said the Advent investment will accelerate growth and strengthen the balance sheet. Voting results from the scrutiniser will be filed separately.

Likely market impact

Pivotal vote on Advent backed Rasmalai capital infusion. Await results — deal may dilute existing holders while bringing growth capital and a global PE backer.